Trial · NCT00970281
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Positive and Negative Syndrome Scale-Excited Component (PANSS-EC) Total Score up to 2 Hours After the First Intramuscular (IM) Injection | 10 mg Olanzapine | -9.2 | Standard Deviation 4.5 | units on a scale | |
| Change From Baseline in the Positive and Negative Syndrome Scale-Excited Component (PANSS-EC) Total Score up to 2 Hours After the First Intramuscular (IM) Injection | Placebo | -2.8 | Standard Deviation 5.6 | units on a scale | |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 0.25 hour after First IM Injection | -2.4 | Standard Deviation 2.9 | units on a scale |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | Placebo | 0.25 hour after First IM Injection | -1.0 | Standard Deviation 3.1 | units on a scale |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 0.50 hour after First IM Injection | -5.0 | Standard Deviation 3.6 | units on a scale |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | Placebo | 0.50 hour after First IM Injection | -1.9 | Standard Deviation 4.6 | units on a scale |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 1 hour after First IM Injection | -7.3 | Standard Deviation 4.9 | units on a scale |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | Placebo | 1 hour after First IM Injection | -3.0 | Standard Deviation 5.2 | units on a scale |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 1.5 hour after First IM Injection | -8.2 | Standard Deviation 4.7 | units on a scale |
| Change From Baseline in PANSS-EC Total Score up to 90 Minutes After the First Intramuscular (IM) Injection | Placebo | 1.5 hour after First IM Injection | -2.7 | Standard Deviation 5.0 | units on a scale |
| Change From Baseline in the Positive and Negative Syndrome Scale - Excited Component (PANSS-EC) Total Score up to 24 Hours After the First Intramuscular (IM) Injection | 10 mg Olanzapine | -5.6 | Standard Deviation 5.8 | units on a scale | |
| Change From Baseline in the Positive and Negative Syndrome Scale - Excited Component (PANSS-EC) Total Score up to 24 Hours After the First Intramuscular (IM) Injection | Placebo | -2.8 | Standard Deviation 6.4 | units on a scale | |
Percentage of Participants With 40% or Greater Percent Decrease in the Positive and Negative Syndrome Scale - Excited Component (PANSS-EC) Total Score up to 2 Hours After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 40.0 | percentage of participants | ||
Percentage of Participants With 40% or Greater Percent Decrease in the Positive and Negative Syndrome Scale - Excited Component (PANSS-EC) Total Score up to 2 Hours After the First Intramuscular (IM) Injection | Placebo | 13.6 | percentage of participants | ||
| Percentage of Participants With Scores of 4 to 7 in the Agitation-Calmness Evaluation Scale (ACES) Score up to 24 Hours After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 0.5 hour after First IM Injection | 24.4 | percentage of participants | |
| Percentage of Participants With Scores of 4 to 7 in the Agitation-Calmness Evaluation Scale (ACES) Score up to 24 Hours After the First Intramuscular (IM) Injection | Placebo | 0.5 hour after First IM Injection | 11.4 | percentage of participants | |
| Percentage of Participants With Scores of 4 to 7 in the Agitation-Calmness Evaluation Scale (ACES) Score up to 24 Hours After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 1 hour after First IM Injection | 31.1 | percentage of participants | |
| Percentage of Participants With Scores of 4 to 7 in the Agitation-Calmness Evaluation Scale (ACES) Score up to 24 Hours After the First Intramuscular (IM) Injection | Placebo | 1 hour after First IM Injection | 15.9 | percentage of participants | |
| Percentage of Participants With Scores of 4 to 7 in the Agitation-Calmness Evaluation Scale (ACES) Score up to 24 Hours After the First Intramuscular (IM) Injection | 10 mg Olanzapine | 1.5 hours after First IM Injection | 40.0 | percentage of participants | |
| Percentage of Participants With Scores of 4 to 7 in the Agitation-Calmness Evaluation Scale (ACES) Score up to 24 Hours After the First Intramuscular (IM) Injection | Placebo | 1.5 hours after First IM Injection | 13.6 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00970281/results